Paydirt
KO
Insider

Kristen M Oelschlager

Chief Operating Officer · Castle Biosciences

Kristen M Oelschlager (Chief Operating Officer) filed 7 Form 4 reports in the trailing twelve months (0 purchases, 7 sales), most often in Castle Biosciences, Inc. (CSTL). The largest single filing was $838K of CSTL (24,602 sh across 3 lots, as filed), executed Aug 24. Data as of Nov 8 2026.

Add to watchlist
Return, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
7
0 buys · 7 sells
Median delay
–
measured on stock purchases
Volume, ttmiDollar value disclosed in the trailing twelve months
$2.0M
shares × price, as filed
Last traded
Oct 1
Filed Oct 5

Median ADV $11.6M across their filed names

Open performance→
Volume by month
$1.4M$686K$0Dec 2024Jun 2025Dec 2025Jun 2026Aug 2025 · sells $670KNov 2025 · sells $1.4MDec 2025 · sells $585KJun 2026 · sells $178KJul 2026 · sells $200KAug 2026 · sells $972KOct 2026 · sells $100K
Buys $0 Sells $4.1M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on
Healthcare 7 filings

Sector per market data · by filing · past 12 months

Most traded names
CSTL Castle Biosciences, Inc. CSTL · 0 buys · 11 sells 11 filings
Recent filings
CSTLSALE Castle Biosciences, Inc. View filing → $391K
18,007 sh × $21.69
Exec Aug 27 2025
Filed Nov 4 2025 · 5:30 PM ET †
CSTLSALE Castle Biosciences, Inc. View filing → $391K
18,007 sh × $21.69
Exec Aug 27 2025
Filed Aug 29 2025 · 5:30 PM ET
CSTLSALE Castle Biosciences, Inc. View filing → $279K
12,677 sh × $22.02
Exec Aug 27 2025
Filed Aug 29 2025 · 5:30 PM ET